Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
NDRAENDRA Life Sciences Inc.
| Figure | NDRAENDRA Life Sciences Inc.FY2020 · Dec |
|---|---|
| Revenue | $0.00 |
| Revenue, yoy | — |
| Net income | $7.03M |
| Net income, yoy | +38.9% |
| Net margin | — |
| Free cash flow | $5.20M |
| FCF margin | — |
| EPS, diluted | $8.93 |
Add another company.
Annual · FY2016–FY2020 · USD
From SEC EDGARSame fiscal periods, as filed